These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 34077480)

  • 1. Correction: The first wave of the SARS-CoV-2 epidemic in Tuscany (Italy): A SI2R2D compartmental model with uncertainty evaluation.
    PLOS ONE Staff
    PLoS One; 2021; 16(6):e0252908. PubMed ID: 34077480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The first wave of the SARS-CoV-2 epidemic in Tuscany (Italy): A SI2R2D compartmental model with uncertainty evaluation.
    Baccini M; Cereda G; Viscardi C
    PLoS One; 2021; 16(4):e0250029. PubMed ID: 33882085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis and future scenarios of the SARS-CoV-2 epidemic in Tuscany Region (Central Italy)].
    Cereda G; Viscardi C; Gottard A; Mealli F; Baccini M
    Epidemiol Prev; 2020; 44(5-6 Suppl 2):120-127. PubMed ID: 33412802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction: Covid-19 in outpatients-Is fever a useful indicator for SARS-CoV-2 infection?
    Schneider A; Kirsten H; Lordick F; Lordick F; Lübbert C; von Braun A
    PLoS One; 2021; 16(5):e0251623. PubMed ID: 33956896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covid-19 Outbreak Progression in Italian Regions: Approaching the Peak by the End of March in Northern Italy and First Week of April in Southern Italy.
    Distante C; Piscitelli P; Miani A
    Int J Environ Res Public Health; 2020 Apr; 17(9):. PubMed ID: 32349259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction: Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda, Angola.
    Sebastião CS; Neto Z; Martinez P; Jandondo D; Antonio J; Galangue M; de Carvalho M; David K; Miranda J; Afonso P; Inglês L; Carrelero RR; de Vasconcelos JN; Morais J
    PLoS One; 2021; 16(5):e0252254. PubMed ID: 34015031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction: Detection of SARS-CoV-2 RNA by direct RT-qPCR on nasopharyngeal specimens without extraction of viral RNA.
    Hasan MR; Mirza F; Al-Hail H; Sundararaju S; Xaba T; Iqbal M; Alhussain H; Yassine HM; Perez-Lopez A; Tang P
    PLoS One; 2020; 15(10):e0240343. PubMed ID: 33007037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction: Identifying key determinants and dynamics of SARS-CoV-2/ACE2 tight interaction.
    Ngo VA; Jha RK
    PLoS One; 2021; 16(11):e0259705. PubMed ID: 34731214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction: Scientific quality of COVID-19 and SARS CoV-2 publications in the highest impact medical journals during the early phase of the pandemic: A case control study.
    Zdravkovic M; Berger-Estilita J; Zdravkovic B; Berger D
    PLoS One; 2021; 16(4):e0250141. PubMed ID: 33831113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction: SARS-CoV-2 transmission routes from genetic data: A Danish case study.
    PLOS ONE Staff
    PLoS One; 2021; 16(12):e0261892. PubMed ID: 34932605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction: Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Lau YL; Ismail IB; Mustapa NIB; Lai MY; Tuan Soh TS; Haji Hassan A; Peariasamy KM; Lee YL; Abdul Kahar MKB; Chong J; Goh PP
    PLoS One; 2021; 16(3):e0249100. PubMed ID: 33735245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correction: Comparative analysis of various clinical specimens in detection of SARS-CoV-2 using rRT-PCR in new and follow up cases of COVID-19 infection: Quest for the best choice.
    Sharma K; Agarwala P; Gandhi D; Mathias A; Singh P; Sharma S; Negi SS; Bhargava A; Das P; Gaikwad U; Wankhede A; Behra A; Nagarkar NM
    PLoS One; 2021; 16(6):e0253355. PubMed ID: 34111217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction: Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders.
    Marklund E; Leach S; Axelsson H; Nyström K; Norder H; Bemark M; Angeletti D; Lundgren A; Nilsson S; Andersson LM; Yilmaz A; Lindh M; Liljeqvist JÅ; Gisslén M
    PLoS One; 2021; 16(10):e0258401. PubMed ID: 34606511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correction: Evaluation of the diagnostic performance of PanbioTM Abbott SARS-CoV-2 rapid antigen test for the detection of COVID-19 from suspects attending ALERT center.
    Ashagre W; Atnafu A; Wassie L; Tschopp R; Fentahun D; Assefa G; Wegayehu T; Wondale B; Mulu A; Mihret A; Bobosha K
    PLoS One; 2024; 19(7):e0307338. PubMed ID: 38995947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the SARS-CoV-2 epidemic in Italy: The role of local and interventional factors in the control of the epidemic.
    Lilleri D; Zavaglio F; Gabanti E; Gerna G; Arbustini E
    PLoS One; 2020; 15(11):e0242305. PubMed ID: 33180880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correction: Factors associated with SARS-COV-2 positive test in Lifelines.
    Sidorenkov G; Vonk JM; Grzegorczyk M; Cortés-Ibañez FO; de Bock GH
    PLoS One; 2024; 19(4):e0302619. PubMed ID: 38640095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correction: High level SARS-CoV-2 nucleocapsid refolding using mild condition for inclusion bodies solubilization: Application of high pressure at pH 9.0.
    PLOS ONE Staff
    PLoS One; 2022; 17(7):e0271140. PubMed ID: 35788214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction: Biochemical characterization of protease activity of Nsp3 from SARS-CoV-2 and its inhibition by nanobodies.
    Armstrong LA; Lange SM; Cesare V; Matthews SP; Nirujogi RS; Cole I; Hope A; Cunningham F; Toth R; Mukherjee R; Bojkova D; Gruber F; Gray D; Wyatt PG; Cinatl J; Dikic I; Davies P; Kulathu Y
    PLoS One; 2024; 19(4):e0302418. PubMed ID: 38626090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction: Seroprevalence of SARS-CoV-2 antibodies and retrospective mortality in a refugee camp, Dagahaley, Kenya.
    Gignoux E; Athanassiadis F; Yarrow AG; Jimale A; Mubuto N; Déglise C; Mosoti DO; Azman AS; Mwau M; Luquero F; Ciglenecki I
    PLoS One; 2024; 19(2):e0299117. PubMed ID: 38354210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction: Harnessing the power of AI: Advanced deep learning models optimization for accurate SARS-CoV-2 forecasting.
    Tariq MU; Ismail SB; Babar M; Ahmad A
    PLoS One; 2023; 18(12):e0296111. PubMed ID: 38096185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.